Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions
Modern Pathology2013Vol. 26(7), pp. 975–983
Citations Over TimeTop 10% of 2013 papers
Martina Kluth, Jana Hesse, Anna Heinl, Antje Krohn, Stefan Steurer, Hüseyin Sirma, Ronald Simon, Pascale-Sophia Mayer, Udo Schumacher, Katharina Grupp, Jakob R. Izbicki, Klaus Pantel, Ekkehard Dikomey, Jan O. Korbel, Christoph Plass, Guido Sauter, Thorsten Schlomm, Sarah Minner
Related Papers
- → Delineation of TMPRSS2-ERG Splice Variants in Prostate Cancer(2008)96 cited
- → Association of ERG and TMPRSS2‐ERG with grade, stage, and prognosis of prostate cancer is dependent on their expression levels(2015)65 cited
- → Combined analysis of TMPRSS2–ERG and TERT for improved prognosis of biochemical recurrence in prostate cancer(2012)23 cited
- Structure and expression of TMPRSS2-ERG splice variants in prostate cancer(2008)
- → Figure S2 from Loss of FOXO1 Cooperates with TMPRSS2–ERG Overexpression to Promote Prostate Tumorigenesis and Cell Invasion(2023)